Safety and usefulness of minor salivary gland biopsy: Retrospective analysis of 502 procedures performed at a single center

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Objective. To analyze the safety of our biopsy technique and the effectiveness of minor salivary gland biopsy (MSGB) for the diagnosis of Sjögren's syndrome (SS) and amyloidosis. Methods. We conducted a retrospective analysis of 452 patients with suspected SS and 50 with suspected amyloidosis and negative periumbilical fat aspiration analysis who underwent MSGB at a single center. Diagnostic evaluation for SS included Schirmer's test, unstimulated whole salivary flow, detection of antinuclear antibodies and anti-SSA/SSB, erythrocyte sedimentation rate, C-reactive protein, IgM rheumatoid factor, and serology for hepatitis C virus. For all biopsy samples, a cumulative focus score on multilevel sections was calculated. SS was diagnosed according to American-European Consensus Group (AECG) criteria. Histologic evaluation for amyloidosis was performed using Congo red staining and polarized-light microscopy. Adverse events were recorded on a questionnaire immediately after the procedure and 7 days, 14 days, and 6 months thereafter. Results. Sixty-four patients (12.7%) reported transient adverse events: 40 paresthesias lasting

Original languageEnglish
Pages (from-to)714-720
Number of pages7
JournalArthritis Care and Research
Volume59
Issue number5
DOIs
Publication statusPublished - May 15 2008

Fingerprint

Minor Salivary Glands
Amyloidosis
Biopsy
Safety
Polarization Microscopy
Congo Red
Paresthesia
Rheumatoid Factor
Antinuclear Antibodies
Blood Sedimentation
Serology
Hepacivirus
C-Reactive Protein
Immunoglobulin M
Fats
Staining and Labeling

ASJC Scopus subject areas

  • Rheumatology

Cite this

@article{49378a6673474d50a963b933a52edcc0,
title = "Safety and usefulness of minor salivary gland biopsy: Retrospective analysis of 502 procedures performed at a single center",
abstract = "Objective. To analyze the safety of our biopsy technique and the effectiveness of minor salivary gland biopsy (MSGB) for the diagnosis of Sj{\"o}gren's syndrome (SS) and amyloidosis. Methods. We conducted a retrospective analysis of 452 patients with suspected SS and 50 with suspected amyloidosis and negative periumbilical fat aspiration analysis who underwent MSGB at a single center. Diagnostic evaluation for SS included Schirmer's test, unstimulated whole salivary flow, detection of antinuclear antibodies and anti-SSA/SSB, erythrocyte sedimentation rate, C-reactive protein, IgM rheumatoid factor, and serology for hepatitis C virus. For all biopsy samples, a cumulative focus score on multilevel sections was calculated. SS was diagnosed according to American-European Consensus Group (AECG) criteria. Histologic evaluation for amyloidosis was performed using Congo red staining and polarized-light microscopy. Adverse events were recorded on a questionnaire immediately after the procedure and 7 days, 14 days, and 6 months thereafter. Results. Sixty-four patients (12.7{\%}) reported transient adverse events: 40 paresthesias lasting",
author = "Roberto Caporali and Eleonora Bonacci and Oscar Epis and Francesca Bobbio-Pallavicini and Patrizia Morbini and Carlomaurizio Montecucco",
year = "2008",
month = "5",
day = "15",
doi = "10.1002/art.23579",
language = "English",
volume = "59",
pages = "714--720",
journal = "Arthritis care and research : the official journal of the Arthritis Health Professions Association",
issn = "0893-7524",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Safety and usefulness of minor salivary gland biopsy

T2 - Retrospective analysis of 502 procedures performed at a single center

AU - Caporali, Roberto

AU - Bonacci, Eleonora

AU - Epis, Oscar

AU - Bobbio-Pallavicini, Francesca

AU - Morbini, Patrizia

AU - Montecucco, Carlomaurizio

PY - 2008/5/15

Y1 - 2008/5/15

N2 - Objective. To analyze the safety of our biopsy technique and the effectiveness of minor salivary gland biopsy (MSGB) for the diagnosis of Sjögren's syndrome (SS) and amyloidosis. Methods. We conducted a retrospective analysis of 452 patients with suspected SS and 50 with suspected amyloidosis and negative periumbilical fat aspiration analysis who underwent MSGB at a single center. Diagnostic evaluation for SS included Schirmer's test, unstimulated whole salivary flow, detection of antinuclear antibodies and anti-SSA/SSB, erythrocyte sedimentation rate, C-reactive protein, IgM rheumatoid factor, and serology for hepatitis C virus. For all biopsy samples, a cumulative focus score on multilevel sections was calculated. SS was diagnosed according to American-European Consensus Group (AECG) criteria. Histologic evaluation for amyloidosis was performed using Congo red staining and polarized-light microscopy. Adverse events were recorded on a questionnaire immediately after the procedure and 7 days, 14 days, and 6 months thereafter. Results. Sixty-four patients (12.7%) reported transient adverse events: 40 paresthesias lasting

AB - Objective. To analyze the safety of our biopsy technique and the effectiveness of minor salivary gland biopsy (MSGB) for the diagnosis of Sjögren's syndrome (SS) and amyloidosis. Methods. We conducted a retrospective analysis of 452 patients with suspected SS and 50 with suspected amyloidosis and negative periumbilical fat aspiration analysis who underwent MSGB at a single center. Diagnostic evaluation for SS included Schirmer's test, unstimulated whole salivary flow, detection of antinuclear antibodies and anti-SSA/SSB, erythrocyte sedimentation rate, C-reactive protein, IgM rheumatoid factor, and serology for hepatitis C virus. For all biopsy samples, a cumulative focus score on multilevel sections was calculated. SS was diagnosed according to American-European Consensus Group (AECG) criteria. Histologic evaluation for amyloidosis was performed using Congo red staining and polarized-light microscopy. Adverse events were recorded on a questionnaire immediately after the procedure and 7 days, 14 days, and 6 months thereafter. Results. Sixty-four patients (12.7%) reported transient adverse events: 40 paresthesias lasting

UR - http://www.scopus.com/inward/record.url?scp=43549124592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43549124592&partnerID=8YFLogxK

U2 - 10.1002/art.23579

DO - 10.1002/art.23579

M3 - Article

C2 - 18438907

AN - SCOPUS:43549124592

VL - 59

SP - 714

EP - 720

JO - Arthritis care and research : the official journal of the Arthritis Health Professions Association

JF - Arthritis care and research : the official journal of the Arthritis Health Professions Association

SN - 0893-7524

IS - 5

ER -